GWAVE
Hagar is the developer of GWave, a non-invasive continuous glucose monitoring technology solution that uses RF waves to measure glucose levels in the blood continuously.
GWAVE
Industry:
Health Care Medical Device
Founded:
2017-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.hagartech.com
Status:
Active
Total Funding:
16.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google Google Cloud Sectigo SSL Sectigo Domain SSL
Similar Organizations
Genetron Health
Genetron Health is a world-leading expert in precision medicine.
GraphWear Technologies
The world's first needle free continuous health monitoring platform
Health2Sync
Health2Sync develops systems that transform smartphones into legacy medical devices and smart health monitoring machines.
Movano
Movano develops a wearable, non-invasive continuous glucose monitor (CGM) that is painless, simple, and smart.
Nutrix
Reshaping the future of healthcare
Current Employees Featured
Founder
Investors List
Columbia Pacific Advisors
Columbia Pacific Advisors investment in Series B - GWave
Columbia Pacific Advisors
Columbia Pacific Advisors investment in Series A - GWave
Official Site Inspections
http://www.hagartech.com Semrush global rank: 5.63 M Semrush visits lastest month: 1.5 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "GWave"
Hagar Company Profile - Office Locations, Competitors, Revenue …
Hagar $16.1 m in total funding,. See insights on Hagar including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
HAGAR - Overview, News & Similar companies | ZoomInfo.com
View HAGAR (www.hagartech.com) location in Tel Aviv, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»
GWAVE
Non-invasive Glucose Monitoring Utilizes RF Wave technology that monitors glucose levels in the blood continuously and in real-time. User safety is our foremost priority, using significantly less …See details»
GWave - Crunchbase Company Profile & Funding
Hagar is the developer of GWave, a non-invasive continuous glucose monitoring technology solution that uses RF waves to measure glucose levels in the blood continuously.See details»
HagarTech - Products, Competitors, Financials, Employees, …
About HagarTech. Hagar specializes in the domain of non-invasive glucose monitoring. The company uses radio frequency waves and proprietary AI algorithms to continuously measure …See details»
Round B - GWAVE
HAGAR, the developer of GWave, the world's first non-invasive continuous glucose monitoring technology that uses RF waves to measure glucose levels in the blood, today announced an …See details»
HAGAR - SPEEDA Edge
HAGAR is an Israeli diabetes monitoring platform that offers a non-invasive glucometer. HAGAR’s flagship product, GWave, is a sensor-enabled glucose monitoring system that uses radio …See details»
Co-Founder & Chief Executive Officer at HAGAR - ZoomInfo
May 6, 2024 About ; Company ; Org Chart ; News & Media ; Similar Profiles ; About Guy Zur Guy Zur is the Co-Founder & Chief Executive Officer at HAGAR based in Tel Aviv, Tel Aviv.See details»
Noninvasive Glucose monitoring company Hagartech
Jul 16, 2021 Israel based healthcare product startup Hagartech, has just announced their Series A funding of USD 4.4 million. It is one of the biggest Series A funding for a blood glucose …See details»
GWave Company Profile 2024: Valuation, Funding & Investors
GWave General Information Description. Developer of a noninvasive glucometer device designed to improve the quality of life for diabetes patients. The company's device is a sensor that can be inserted into a ceramic, lightweight, comfortable bracelet worn on the wrist that sends glucose readings to the user via a smartphone app that can easily be shared with their healthcare …See details»
Study Sheds Light on Hagar’s Non-Invasive Glucose Monitoring …
Mar 23, 2023 New Study Sheds Light on Hagar’s Non-Invasive Glucose Monitoring System. The Tel Aviv, Israel-based company uses RF waves to measure glucose in the blood.See details»
hagartech.com - Home | GWAVE - Hagartech - Sur.ly
Hagartech.com most likely does not offer any adult content. Popular pages. Home | GWAVE. Non-invasive Glucose Monitoring Utilizes RF Wave technology that monitors glucose levels in …See details»
HAGAR Announces Preliminary Results of Study For Its Non …
Mar 22, 2023 HAGAR, the developer of GWave, a revolutionary non-invasive continuous glucose monitoring technology that uses RF waves to measure glucose levels in tSee details»
medtech-insight - GWAVE
Hagar is planning to put its GWave non-invasive continuous glucose monitoring (CGM) technology in a smartwatch and eventually sell the technology to a larger medtech player that can market it globally.See details»
Hagar gets FDA breakthrough device designation for GWave …
Nov 24, 2021 Hagar N.I.G. (Noninvasive Glucose monitoring) has received the US Food and Drug Administration (FDA) breakthrough device designation for its GWave technology.See details»
Round A - GWAVE
Tel Aviv, Israel - July 7th, 2021: Globally, more than 460 million adults have diabetes. But testing for glucose up to 10 times a day using invasive products not only increases the risk of infection …See details»
HAGAR Secures $11.7M Series B Funding to ... - G-MedTech News …
May 13, 2024 HAGAR, the developer of GWave, the world’s first non-invasive continuous glucose monitoring technology that uses RF waves to measure glucose levels in the blood, …See details»
HAGAR Unveils New Clinical Data on Groundbreaking GWave …
Aug 10, 2023 HAGAR, the developer of GWave, a non-invasive continuous glucose monitoring technology that uses RF (radio frequency) waves to measure glucose levelsSee details»
Diabetes startup brews up $11M after 'serendipitous spill' led to ...
Aug 12, 2021 Backed by those promising results, and with Hagar now planning to launch clinical trials to pursue FDA approval of the GWave system, the company has raised $11.7 million in …See details»
连续血糖监测技术开发商Hagar公布GWave技术临床数据-动脉网
Jun 19, 2024 This study, recently published in Diabetes Technology & Therapeutics, highlights the impressive precision of GWave technology. Among 75 participants—including those with …See details»